Multi-Immune Agonist Nanoparticle Therapy Stimulates Type I Interferons to Activate Antigen-Presenting Cells and Induce Antigen-Specific Antitumor Immunity-Reference-Cited by-同舟云学术

Multi-Immune Agonist Nanoparticle Therapy Stimulates Type I Interferons to Activate Antigen-Presenting Cells and Induce Antigen-Specific Antitumor Immunity

Published:2021-02-04 Issue:3 Volume:18 Page:1014-1025
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Levy Elizabeth S.¹,Chang Ryan¹²,Zamecnik Colin R.¹,Dhariwala Miqdad O.³,Fong Lawrence⁴⁵,Desai Tejal A.¹^ORCID

Affiliation:

1. Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California 94158, United States

2. Department of Medicine, University of California San Francisco, San Francisco, California 94143, United States

3. Department of Dermatology, University of California San Francisco, San Francisco, California 94143, United Stats

4. Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, California 94143, United States

5. Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, California 94143, United States

Funder

University of California

American Foundation for Pharmaceutical Education

U.S. Department of Health and Human Services

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.0c00984

Reference68 articles.

1. Crosstalk between cancer and immune cells: Role of tumor‐associated macrophages in the tumor microenvironment

2. Immune evasion in cancer: Mechanistic basis and therapeutic strategies

3. Immune escape as a fundamental trait of cancer: focus on IDO

4. Updates in the Clinical Development of Epacadostat and Other Indoleamine 2,3-Dioxygenase 1 Inhibitors (IDO1) for Human Cancers

5. Dembic, Z. CThe Cytokines of the Immune System: The Role of Cytokines in Disease Related to Immune Response; Academic Press, 2015; pp 123–142.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanocarrier design for pathogen-inspired innate immune agonist delivery;Trends in Immunology;2024-09

2. Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy;Biomarker Research;2024-01-07

3. Overcoming challenges in the delivery of STING agonists for cancer immunotherapy: A comprehensive review of strategies and future perspectives;Materials Today Bio;2023-12

4. Immunotherapy with STING and TLR9 agonists promotes synergistic therapeutic efficacy with suppressed cancer-associated fibroblasts in colon carcinoma;Frontiers in Immunology;2023-10-13

5. Targeted immune activation in pediatric solid tumors: opportunities to complement local control approaches;Frontiers in Immunology;2023-06-22